2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow Autosomal Dominant Hypocalcemia (ADH): new trials by email Literature Review of Autosomal Dominant Hypocalcemia (ADH) trials Research Report on Autosomal Dominant Hypocalcemia (ADH)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety, Tolerability, and Efficacy of Encaleret in Participants With Autosomal Dominant Hypocalcemia (ADH) Type 1 Encaleret - Autosomal Dominant Hypocalcemia (ADH), Autosomal Dominant Hypocalcemia Type 1 (ADH1) | Phase 2 | Completed | Calcilytix Therapeutics, Inc., a BridgeBio company | 13 | 2020-09-20 | 2024-11-19 |
| A Study to Determine the Effects of NPSP795 on the Calcium-sensing Receptor in Subjects With Autosomal Dominant Hypocalcemia as Measured by PTH Levels and Blood Calcium Concentrations NPSP795 - Autosomal Dominant Hypocalcemia (ADH) | Phase 2 | Completed | Shire | 7 | 2014-07-18 | 2021-08-09 |
Hypercalciuric Hypocalcemia, Familial (2) · Hypocalcemia (1) · Hypoparathyroidism (1)
Calcium Metabolism Disorders (1) · Endocrine System Diseases (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1) · Parathyroid Diseases (1) · Water-Electrolyte Imbalance (1)
Calcilytix Therapeutics, Inc., a BridgeBio company (1) · Shire (1)
United States (2)